4 not yet recruiting, 3 recruiting, 2 active not recruiting. 2 Phase 4, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 2 | Not yet recruiting 2 |
| Phase 3 | 1 | Active not recruiting 1 |
Follow Takayasu Arteritis (TAK): new trials by email Literature Review of Takayasu Arteritis (TAK) trials Research Report on Takayasu Arteritis (TAK)
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Monitoring Disease Activity in Patients With Takayasu Arteritis With the OMERACT Takayasu Ultrasound Score (OTUS) Takayasu Arteritis (TAK) | Not yet recruiting | IRCCS San Raffaele | 100 | 2026-07-01 | 2026-05-11 | |
| Efficacy and Safety of Vunakizumab and Ivarmacitinib in the Treatment of Active Takayasu's Arteritis Vanakizumab, Ivarmacitinib, Prednisone - Takayasu Arteritis (TAK) | Phase 4 | Not yet recruiting | Chinese SLE Treatment And Research Group | 180 | 2026-04-01 | 2026-03-05 |
| Investigating Management, Perspectives and Attitudes Towards Care in Takayasu Arteritis Questionnaire - Takayasu Arteritis, Takayasu Arteritis (TAK) | Recruiting | University of Edinburgh | 50 | 2025-10-01 | 2026-01-20 | |
| Global Initiative on Takayasu Arteritis (GITA) Takayasu Arteritis (TAK), Takayasu's Arteritis | Recruiting | Marmara University | 1000 | 2025-08-05 | 2026-04-30 | |
| The Efficacy and Safety of Deucravacitinib in Takayasu's Arteritis Deucravacitinib, Adalimumab - Takayasu Arteritis (TAK) | Phase 4 | Not yet recruiting | Chinese SLE Treatment And Research Group | 50 | 2025-06-15 | 2025-06-10 |
| A Registry Study Assessing PRO, Dosing Patterns, and Safety of Vunakizumab in Patients With General Rheumatic Diseases. Ankylosing Spondylitis (AS), Psoriatic Arthritis (PsA) | Not yet recruiting | Second Affiliated Hospital, Zhejiang University, School of Medicine | 10000 | 2025-01-30 | 2025-01-09 | |
| Evaluation of Platelet Aggregability in Patients with Takayasu's Arteritis Clopidogrel - Takayasu Arteritis (TAK), Vasculitis, Systemic | Active not recruiting | Jose Carlos Nicolau | 100 | 2024-10-14 | 2025-02-04 | |
| A Study to Evaluate the Efficacy and Safety of Upadacitinib in Participants With Takayasu Arteritis (TAK) Upadacitinib, Placebo for Upadacitinib, Prednisolone - Takayasu Arteritis (TAK) | Phase 3 | Active not recruiting | AbbVie | 56 | 2020-02-04 | 2026-02-18 |
| Vasculitis Pregnancy Registry Online questionnaires - Vasculitis, Behcet's Disease | Recruiting | University of Pennsylvania | 100 | 2015-11-01 | 2026-01-23 |
Takayasu Arteritis (9) · Systemic Vasculitis (2) · Arthritis, Juvenile (1) · Arthritis, Psoriatic (1) · Behcet Syndrome (1) · Churg-Strauss Syndrome (1) · Cryoglobulinemia, Familial Mixed (1) · Giant Cell Arteritis (1) · Granulomatosis with Polyangiitis (1) · IgA Vasculitis (1) · Microscopic Polyangiitis (1) · Non-Radiographic Axial Spondyloarthritis (1) · Polyarteritis Nodosa (1) · Polymyalgia Rheumatica (1) · Recurrence (1)
Aortic Arch Syndromes (9) · Aortic Diseases (9) · Arteritis (9) · Cardiovascular Diseases (9) · Skin Diseases (9) · Skin Diseases, Vascular (9) · Skin and Connective Tissue Diseases (9) · Vascular Diseases (9) · Vasculitis (8) · Autoimmune Diseases (2) · Autoimmune Diseases of the Nervous System (2) · Brain Diseases (2) · Central Nervous System Diseases (2) · Cerebrovascular Disorders (2) · Immune System Diseases (2)
Adalimumab (1) · Clopidogrel (1) · Prednisolone (1) · Prednisone (1) · Surveys and Questionnaires (1) · deucravacitinib (1) · ivarmacitinib (1) · upadacitinib (1)
Chinese SLE Treatment And Research Group (2) · AbbVie (1) · IRCCS San Raffaele (1) · Jose Carlos Nicolau (1) · Marmara University (1) · Second Affiliated Hospital, Zhejiang University, School of Medicine (1) · University of Edinburgh (1) · University of Pennsylvania (1)
China (4) · Brazil (2) · Turkey (Türkiye) (2) · Argentina (1) · Japan (1) · South Korea (1) · United Kingdom (1) · United States (1)
Megan Clowse, MD, MPH (1) · Peter A Merkel, MD, MPH (1) · Xinping Tian, MD (1)